Our results, similarly to the aforementioned studies, suggest that the statistical strength of S100B in determining long-term functional outcome in ischemic stroke is similar for all patients, irrespective of the introduced treatment (Figures S5–S7). The gene discussed is S100B; the disease is ischemic stroke.